BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33407897)

  • 21. The DNA copy number landscape of a collision tumor.
    Kearney H; Cryan JB; Looby S; Brett FM; Farrell MA; Buckley PG
    Clin Neuropathol; 2018; 37(2):68-73. PubMed ID: 29350171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature.
    Sahm F; Toprak UH; Hübschmann D; Kleinheinz K; Buchhalter I; Sill M; Stichel D; Schick M; Bewerunge-Hudler M; Schrimpf D; Zadeh G; Aldape K; Herold-Mende C; Beck K; Staszewski O; Prinz M; Harosh CB; Eils R; Sturm D; Jones DTW; Pfister SM; Paulus W; Ram Z; Schlesner M; Grossman R; von Deimling A
    Acta Neuropathol; 2017 Jul; 134(1):155-158. PubMed ID: 28474103
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic/molecular alterations of meningiomas and the signaling pathways targeted.
    Domingues P; González-Tablas M; Otero Á; Pascual D; Ruiz L; Miranda D; Sousa P; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
    Oncotarget; 2015 May; 6(13):10671-88. PubMed ID: 25965831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.
    Kalamarides M; Stemmer-Rachamimov AO; Takahashi M; Han ZY; Chareyre F; Niwa-Kawakita M; Black PM; Carroll RS; Giovannini M
    Brain Pathol; 2008 Jan; 18(1):62-70. PubMed ID: 17924978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
    Brastianos PK; Horowitz PM; Santagata S; Jones RT; McKenna A; Getz G; Ligon KL; Palescandolo E; Van Hummelen P; Ducar MD; Raza A; Sunkavalli A; Macconaill LE; Stemmer-Rachamimov AO; Louis DN; Hahn WC; Dunn IF; Beroukhim R
    Nat Genet; 2013 Mar; 45(3):285-9. PubMed ID: 23334667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progestin-associated shift of meningioma mutational landscape.
    Peyre M; Gaillard S; de Marcellus C; Giry M; Bielle F; Villa C; Boch AL; Loiseau H; Baussart B; Cazabat L; Raffin-Sanson ML; Sanson M; Kalamarides M
    Ann Oncol; 2018 Mar; 29(3):681-686. PubMed ID: 29206892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
    Clark VE; Harmancı AS; Bai H; Youngblood MW; Lee TI; Baranoski JF; Ercan-Sencicek AG; Abraham BJ; Weintraub AS; Hnisz D; Simon M; Krischek B; Erson-Omay EZ; Henegariu O; Carrión-Grant G; Mishra-Gorur K; Durán D; Goldmann JE; Schramm J; Goldbrunner R; Piepmeier JM; Vortmeyer AO; Günel JM; Bilgüvar K; Yasuno K; Young RA; Günel M
    Nat Genet; 2016 Oct; 48(10):1253-9. PubMed ID: 27548314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges.
    Fountain DM; Smith MJ; O'Leary C; Pathmanaban ON; Roncaroli F; Bobola N; King AT; Evans DG
    Oncogene; 2021 Feb; 40(5):875-884. PubMed ID: 33262459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mutation landscape of a meningioma and its pulmonary metastasis.
    Du Y; Lu T; Huang S; Ren F; Cui G; Chen J
    Cancer Commun (Lond); 2018 May; 38(1):16. PubMed ID: 29764516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
    Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
    Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.
    Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA
    Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respective roles of Pik3ca mutations and cyproterone acetate impregnation in mouse meningioma tumorigenesis.
    Cômes PC; Le Van T; Tran S; Huard S; Abi-Jaoude S; Venot Q; Marijon P; Boetto J; Blouin A; Bielle F; Ducos Y; Teranishi Y; Kalamarides M; Peyre M
    Cancer Gene Ther; 2023 Aug; 30(8):1114-1123. PubMed ID: 37188724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced expression of schwannomin/merlin in human sporadic meningiomas.
    Lee JH; Sundaram V; Stein DJ; Kinney SE; Stacey DW; Golubić M
    Neurosurgery; 1997 Mar; 40(3):578-87. PubMed ID: 9055299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple spinal meningiomas: a case of 47 distinct lesions in the absence of neurofibromatosis or identified chromosomal abnormality.
    Chaparro MJ; Young RF; Smith M; Shen V; Choi BH
    Neurosurgery; 1993 Feb; 32(2):298-301; discussion 301-2. PubMed ID: 8437669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
    Reuss DE; Piro RM; Jones DT; Simon M; Ketter R; Kool M; Becker A; Sahm F; Pusch S; Meyer J; Hagenlocher C; Schweizer L; Capper D; Kickingereder P; Mucha J; Koelsche C; Jäger N; Santarius T; Tarpey PS; Stephens PJ; Andrew Futreal P; Wellenreuther R; Kraus J; Lenartz D; Herold-Mende C; Hartmann C; Mawrin C; Giese N; Eils R; Collins VP; König R; Wiestler OD; Pfister SM; von Deimling A
    Acta Neuropathol; 2013 Mar; 125(3):351-8. PubMed ID: 23404370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Merlin expression in secretory meningiomas: evidence of an NF2-independent pathogenesis? Immunohistochemical study.
    Buccoliero AM; Gheri CF; Castiglione F; Ammannati F; Gallina P; Taddei A; Garbini F; Rossi Degl'Innocenti D; Arganini L; Di Lorenzo N; Mennonna P; Taddei GL
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):353-7. PubMed ID: 17721284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF2 mutations in secretory and other rare variants of meningiomas.
    Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A
    Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexisting cranial and multiple spinal meningioma in a child-report of a case.
    Shukla SK; Trivedi A; Sharma V; Singh K
    J Neurooncol; 2011 Mar; 102(1):115-9. PubMed ID: 20635118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes.
    Durand A; Champier J; Jouvet A; Labrousse F; Honnorat J; Guyotat J; Fèvre-Montange M
    Clin Neuropathol; 2008; 27(5):334-45. PubMed ID: 18808065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations.
    Libert DM; Prayson RA
    Ann Diagn Pathol; 2020 Jun; 46():151516. PubMed ID: 32311644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.